Differential changes in GPR55 during microglial cell activation

被引:96
作者
Pietr, Maciej [1 ]
Kozela, Ewa [1 ]
Levy, Rivka [1 ]
Rimmerman, Neta [1 ]
Lin, Yi Hsing [2 ,3 ]
Stella, Nephi [2 ,3 ]
Vogel, Zvi [1 ,4 ]
Juknat, Ana [4 ]
机构
[1] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel
[2] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA
[3] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA
[4] Tel Aviv Univ, Sackler Fac Med, Dr Miriam & Sheldon G Adelson Ctr Biol Addict Dis, Tel Aviv, Israel
关键词
Cannabinoid; Microglia; Lipopolysaccharide; Interferon gamma; G protein-coupled receptor 55; CB2; receptor; Lysophosphatidylinositol; ERK phosphorylation; CB2 CANNABINOID RECEPTOR; EXPRESSION; BRAIN; ANANDAMIDE; GAMMA;
D O I
10.1016/j.febslet.2009.05.028
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We examined how lipopolysaccharide (LPS) and interferon gamma (IFN-gamma), known to differentially activate microglia, affect the expression of G protein-coupled receptor 55 (GPR55), a novel cannabinoid receptor. We found that GPR55 mRNA is significantly expressed in both primary mouse microglia and the BV-2 mouse microglial cell line, and that LPS down-regulates this message. Conversely, IFN-gamma slightly decreases GPR55 mRNA in primary microglia, while it upregulates this message in BV-2 cells. Moreover, the GPR55 agonist, lysophosphatidylinositol, increases ERK phosphorylation in BV-2 stimulated with IFN-gamma, in correlation with the increased amount of GPR55 mRNA. Remarkably, these stimuli-induced changes in GPR55 expression are similar to those observed with CB2-R, suggesting that both receptors might be involved in neuroinflammation and that their expression is concomitantly controlled by the state of microglial activation. (C) 2009 Federation of European Biochemical Societies. Published by Elsevier B. V. All rights reserved.
引用
收藏
页码:2071 / 2076
页数:6
相关论文
共 50 条
  • [31] Identification of the GPR55 Antagonist Binding Site Using a Novel Set of High-Potency GPR55 Selective Ligands
    Kotsikorou, Evangelia
    Sharir, Haleli
    Shore, Derek M.
    Hurst, Dow P.
    Lynch, Diane L.
    Madrigal, Karla E.
    Heynen-Genel, Susanne
    Milan, Loribelle B.
    Chung, Thomas D. Y.
    Seltzman, Herbert H.
    Bai, Yushi
    Caron, Marc G.
    Barak, Larry S.
    Croatt, Mitchell P.
    Abood, Mary E.
    Reggio, Patricia H.
    [J]. BIOCHEMISTRY, 2013, 52 (52) : 9456 - 9469
  • [32] The putative cannabinoid receptor GPR55 defines a novel autocrine loop in cancer cell proliferation
    Pineiro, R.
    Maffucci, T.
    Falasca, M.
    [J]. ONCOGENE, 2011, 30 (02) : 142 - 152
  • [33] Effects of a Novel GPR55 Antagonist on the Arachidonic Acid Cascade in LPS-Activated Primary Microglial Cells
    Saliba, Soraya Wilke
    Glaeser, Franziska
    Deckers, Anke
    Keil, Albrecht
    Hurrle, Thomas
    Apweiler, Matthias
    Ferver, Florian
    Volz, Nicole
    Endres, Dominique
    Braese, Stefan
    Fiebich, Bernd L.
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (05) : 1 - 16
  • [34] Possible role of hippocampal GPR55 in spatial learning and memory in rats
    Marichal-Cancino, Bruno A.
    Fajardo-Valdez, Alfonso
    Ruiz-Contreras, Alejandra E.
    Mendez-Diaz, Monica
    Prospero-Garcia, Oscar
    [J]. ACTA NEUROBIOLOGIAE EXPERIMENTALIS, 2018, 78 (01) : 41 - 50
  • [35] The actions and metabolism of lysophosphatidylinositol, an endogenous agonist for GPR55
    Yamashita, Atsushi
    Oka, Saori
    Tanikawa, Takashi
    Hayashi, Yasuhiro
    Nemoto-Sasaki, Yoko
    Sugiura, Takayuki
    [J]. PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2013, 107 : 103 - 116
  • [36] The orphan receptor GPR55 is a novel cannabinoid receptor
    Ryberg, E.
    Larsson, N.
    Sjoegren, S.
    Hjorth, S.
    Hermansson, N-O
    Leonova, J.
    Elebring, T.
    Nilsson, K.
    Drmota, T.
    Geasley, P. J.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2007, 152 (07) : 1092 - 1101
  • [37] GPR55: a new member of the cannabinoid receptor clan?
    Pertwee, R. G.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2007, 152 (07) : 984 - 986
  • [38] Lysophosphatidylinositol Promotes Chemotaxis and Cytokine Synthesis in Mast Cells with Differential Participation of GPR55 and CB2 Receptors
    Martinez-Aguilar, Lizbeth Magnolia
    Ibarra-Sanchez, Alfredo
    Guerrero-Moran, Daniel Jose
    Macias-Silva, Marina
    Munoz-Bello, Jesus Omar
    Padilla, Alejandro
    Lizano, Marcela
    Gonzalez-Espinosa, Claudia
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (07)
  • [39] The GPR55 antagonist CID16020046 mitigates advanced glycation end products (AGEs)- induced chondrocyte activation
    Zeng, Yong
    Liu, Zhichuan
    Tan, Xingqin
    Lei, Lei
    [J]. CHEMICO-BIOLOGICAL INTERACTIONS, 2020, 325
  • [40] The Endocannabinoids Anandamide and Virodhamine Modulate the Activity of the Candidate Cannabinoid Receptor GPR55
    Sharir, Haleli
    Console-Bram, Linda
    Mundy, Christina
    Popoff, Steven N.
    Kapur, Ankur
    Abood, Mary E.
    [J]. JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2012, 7 (04) : 856 - 865